Ignyte Acquisition (NASDAQ:IGNY) Trading 18.6% Higher

Ignyte Acquisition Corp. (NASDAQ:IGNY – Get Rating)’s share price traded up 18.6% on Wednesday . The company traded as high as $0.95 and last traded at $0.95. 152 shares traded hands during trading, a decline of 99% from the average session volume of 26,174 shares. The stock had previously closed at $0.80.

Ignyte Acquisition Stock Up 18.6 %

The company’s fifty day moving average is $1.96 and its 200 day moving average is $2.98.

Institutional Trading of Ignyte Acquisition

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Goldman Sachs Group Inc. raised its position in shares of Ignyte Acquisition by 13.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 27,428 shares of the company’s stock valued at $270,000 after buying an additional 3,276 shares in the last quarter. Radcliffe Capital Management L.P. raised its position in shares of Ignyte Acquisition by 3.8% during the 1st quarter. Radcliffe Capital Management L.P. now owns 103,800 shares of the company’s stock valued at $1,021,000 after buying an additional 3,800 shares in the last quarter. Periscope Capital Inc. raised its position in shares of Ignyte Acquisition by 8.0% during the 3rd quarter. Periscope Capital Inc. now owns 165,031 shares of the company’s stock valued at $1,648,000 after buying an additional 12,264 shares in the last quarter. Smith Moore & CO. purchased a new stake in shares of Ignyte Acquisition during the 3rd quarter valued at $149,000. Finally, Mint Tower Capital Management B.V. purchased a new position in Ignyte Acquisition in the 3rd quarter worth $561,000. Hedge funds and other institutional investors own 61.08% of the company’s stock.

Ignyte Acquisition Company Profile

(Get Rating)

Ignyte Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company intends to focus on target businesses in the life sciences, biotechnology, and healthcare sectors.